loadpatents
Patent applications and USPTO patent grants for KAUFMANN; Jorg.The latest application filed is for "recombinant nucleic acid construct".
Patent | Date |
---|---|
Recombinant Nucleic Acid Construct App 20210261980 - GIESE; Klaus ;   et al. | 2021-08-26 |
Method for Producing Security Elements in an Image Which are not Visible to the Human Eye and Cannot be Copied, and Printed Image App 20210245542 - Kaufmann; Jorg ;   et al. | 2021-08-12 |
Interfering Rna Molecules App 20210062198 - GIESE; Klaus ;   et al. | 2021-03-04 |
Interfering RNA molecules Grant 10,774,332 - Giese , et al. Sept | 2020-09-15 |
Interfering Rna Molecules App 20190390201 - GIESE; Klaus ;   et al. | 2019-12-26 |
Interfering RNA molecules Grant 10,329,568 - Giese , et al. | 2019-06-25 |
Interfering RNA molecules Grant 10,323,246 - Giese , et al. | 2019-06-18 |
Interfering RNA molecules Grant 10,266,829 - Giese , et al. | 2019-04-23 |
Means For Lung Specific Delivery App 20190038557 - KEIL; Oliver ;   et al. | 2019-02-07 |
Interfering Rna Molecules App 20190024089 - GIESE; Klaus ;   et al. | 2019-01-24 |
Interfering Rna Molecules App 20180291381 - Giese; Klaus ;   et al. | 2018-10-11 |
Interfering Rna Molecules App 20180223286 - GIESE; Klaus ;   et al. | 2018-08-09 |
Lipoplex Formulations For Specific Delivery To Vascular Endothelium App 20170296469 - KAUFMANN; JORG ;   et al. | 2017-10-19 |
Interfering RNA molecules Grant 9,790,505 - Giese , et al. October 17, 2 | 2017-10-17 |
Interfering RNA molecules Grant 9,790,501 - Giese , et al. October 17, 2 | 2017-10-17 |
Interfering RNA molecules Grant 9,783,802 - Giese , et al. October 10, 2 | 2017-10-10 |
Interfering RNA molecules Grant 9,758,784 - Giese , et al. September 12, 2 | 2017-09-12 |
Interfering Rna Molecules App 20170247691 - GIESE; Klaus ;   et al. | 2017-08-31 |
Interfering Rna Molecules App 20170247697 - GIESE; Klaus ;   et al. | 2017-08-31 |
Interfering Rna Molecules App 20170247707 - GIESE; Klaus ;   et al. | 2017-08-31 |
Interfering Rna Molecules App 20170247698 - GIESE; Klaus ;   et al. | 2017-08-31 |
Interfering RNA molecules Grant 9,695,423 - Giese , et al. July 4, 2 | 2017-07-04 |
Lipids, Lipid Complexes And Use Thereof App 20170036990 - KEIL; OLIVER ;   et al. | 2017-02-09 |
Means For Lung Specific Delivery App 20160303047 - KEIL; OLIVER ;   et al. | 2016-10-20 |
Means for inhibiting the expression of ANG2 Grant 9,458,461 - Santel , et al. October 4, 2 | 2016-10-04 |
Coated lipid complexes and their use Grant 9,387,262 - Keil , et al. July 12, 2 | 2016-07-12 |
Interfering Rna Molecules App 20160130587 - Giese; Klaus ;   et al. | 2016-05-12 |
Interfering RNA molecules Grant 9,222,092 - Giese , et al. December 29, 2 | 2015-12-29 |
Lipids, Lipid Complexes And Use Thereof App 20150359906 - KEIL; OLIVER ;   et al. | 2015-12-17 |
Further Use Of Protein Kinase N Beta App 20150337382 - KLIPPEL-GIESE; ANKE ;   et al. | 2015-11-26 |
Lipids, lipid complexes and use thereof Grant 9,125,820 - Keil , et al. September 8, 2 | 2015-09-08 |
Further use of protein kinase N beta Grant 9,078,855 - Klippel-Giese , et al. July 14, 2 | 2015-07-14 |
Interfering Rna Molecules App 20150105545 - GIESE; KLAUS ;   et al. | 2015-04-16 |
Coated Lipid Complexes And Their Use App 20150031752 - KEIL; OLIVER ;   et al. | 2015-01-29 |
Interfering RNA molecules Grant 8,933,215 - Giese , et al. January 13, 2 | 2015-01-13 |
Lipids, Lipid Complexes And Use Thereof App 20140329885 - KEIL; OLIVER ;   et al. | 2014-11-06 |
Means For Inhibiting The Expression Of Ang2 App 20140328903 - SANTEL; ANSGAR ;   et al. | 2014-11-06 |
Coated lipid complexes and their use Grant 8,852,472 - Keil , et al. October 7, 2 | 2014-10-07 |
Means for inhibiting the expression of ANG2 Grant 8,829,179 - Santel , et al. September 9, 2 | 2014-09-09 |
Means For Inhibiting The Expression Of Orc-1 App 20140249207 - GOSSEN; MANFRED ;   et al. | 2014-09-04 |
Lipids, lipid complexes and use thereof Grant 8,735,453 - Keil , et al. May 27, 2 | 2014-05-27 |
Means for inhibiting the expression of Orc-1 Grant 8,722,875 - Gossen , et al. May 13, 2 | 2014-05-13 |
Therapeutic uses of inhibitors of RTP801 Grant 8,642,571 - Feinstein , et al. February 4, 2 | 2014-02-04 |
Lipids, Lipid Complexes And Use Thereof App 20130165381 - KEIL; OLIVER ;   et al. | 2013-06-27 |
Interfering Rna Molecules App 20130102769 - GIESE; KLAUS ;   et al. | 2013-04-25 |
Therapeutic Uses Of Inhibitors Of Rtp801 App 20130095117 - Feinstein; Elena ;   et al. | 2013-04-18 |
Lipids, lipid complexes and use thereof Grant 8,357,722 - Keil , et al. January 22, 2 | 2013-01-22 |
Interfering RNA molecules Grant 8,324,370 - Giese , et al. December 4, 2 | 2012-12-04 |
Therapeutic uses of inhibitors of RTP801 Grant 8,309,532 - Feinstein , et al. November 13, 2 | 2012-11-13 |
Means for inhibiting the expression of protein kinase 3 Grant 8,232,256 - Kaufmann , et al. July 31, 2 | 2012-07-31 |
Further Use Of Protein Kinase N Beta App 20120171220 - KLIPPEL-GIESE; ANKE ;   et al. | 2012-07-05 |
Methods of treating eye diseases in diabetic patients Grant 8,168,607 - Feinstein , et al. May 1, 2 | 2012-05-01 |
Lipids, Lipid Complexes And Use Thereof App 20120065138 - KEIL; OLIVER ;   et al. | 2012-03-15 |
Means For Inhibiting The Expression Of Ang2 App 20120022138 - Santel; Ansgar ;   et al. | 2012-01-26 |
Lipids, Lipid Complexes And Use Thereof App 20110294871 - KEIL; OLIVER ;   et al. | 2011-12-01 |
Lipids, lipid complexes and use thereof Grant 8,017,804 - Keil , et al. September 13, 2 | 2011-09-13 |
Means For Inhibiting The Expression Of Orc-1 App 20110217367 - Gossen; Manfred ;   et al. | 2011-09-08 |
Interfering RNA Molecules App 20110118456 - Giese; Klaus ;   et al. | 2011-05-19 |
Therapeutic uses of inhibitors of RTP801 App 20110117102 - Feinstein; Elena ;   et al. | 2011-05-19 |
Interfering RNA molecules Grant 7,893,245 - Giese , et al. February 22, 2 | 2011-02-22 |
Methods of treating eye diseases in diabetic patients App 20110028532 - Feinstein; Elena ;   et al. | 2011-02-03 |
Further Use of Protein Kinase N Beta App 20110008320 - Klippel-Giese; Anke ;   et al. | 2011-01-13 |
Therapeutic uses of inhibitors of RTP801 Grant 7,741,299 - Feinstein , et al. June 22, 2 | 2010-06-22 |
Further use of protein kinase N beta Grant 7,713,943 - Klippel-Giese , et al. May 11, 2 | 2010-05-11 |
Coated Lipid Complexes And Their Use App 20100062967 - Keil; Oliver ;   et al. | 2010-03-11 |
Means for Inhibiting the Expression of Protein Kinase 3 App 20090304678 - Kaufmann; Jorg ;   et al. | 2009-12-10 |
Means For Inhibiting The Expression Of Cd31 App 20090252783 - Kaufmann; Jorg ;   et al. | 2009-10-08 |
Interfering Rna Molecules App 20090186845 - GIESE; KLAUS ;   et al. | 2009-07-23 |
Lipoplex Formulations For Specific Delivery To Vascular Endothelium App 20090074852 - Kaufmann; Jorg ;   et al. | 2009-03-19 |
Interfering RNA molecules Grant 7,452,987 - Giese , et al. November 18, 2 | 2008-11-18 |
Lipids, Lipid Complexes and Use Thereof App 20080274116 - Keil; Oliver ;   et al. | 2008-11-06 |
Interfering RNA molecules App 20040180351 - Giese, Klaus ;   et al. | 2004-09-16 |
Further use of protein kinase N beta App 20040106569 - Klippel-Giese, Anke ;   et al. | 2004-06-03 |
Compounds and methods for the identification and/ or validation of a target App 20030135033 - Klippel-Giese, Anke ;   et al. | 2003-07-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.